• $54.4M
    Market Cap
  • 158.06%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.8M
-39.51%
-3.0M
+56.96%
-1.9M
+52.21%
-1.3M
+52.51%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
3.8M
-11.22%
4.3M
+3.59%
4.2M
+3.90%
4.0M
+10.46%
Operating Profit
-3.8M
-11.22%
-4.3M
+3.59%
-4.2M
+3.90%
-4.0M
+10.46%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-126,476
-81.07%
-668,117
+291.01%
-170,868
-55.06%
-380,230
-16.87%
Interest Income and Expense and Net
-126,476
-81.07%
-668,117
+291.01%
-170,868
-55.06%
-380,230
-16.87%
Total Nonoperating Income and Expense
-672,398
-32.48%
-995,866
+0.35%
-992,415
-31.74%
-1.5M
+57.66%
Income before Taxes
-5.9M
-10.11%
-6.5M
+3.55%
-6.3M
-1.87%
-6.4M
+18.53%
Income Taxes
-1.3M
-14.59%
-1.5M
+96.00%
-754,660
-57.41%
-1.8M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-5.9M
+10.65%
-5.3M
+2.97%
-5.2M
-5.57%
-5.5M
+20.01%
Net Income from Continuing Operations Applicable to Common
-5.9M
-10.11%
-6.5M
+3.55%
-6.3M
-1.87%
-6.4M
+18.53%
Basic EPS and Net Income
-0.14
-17.65%
-0.17
-5.56%
-0.18
-5.26%
-0.19
0.00%
Diluted EPS and Net Income
-0.14
-17.65%
-0.17
-5.56%
-0.18
-5.26%
-0.19
0.00%
Basic Weighted Average Shares
41.9M
+10.81%
37.8M
+8.47%
34.8M
+5.19%
33.1M
+13.81%
Diluted Weighted Average Shares
41.9M
+10.81%
37.8M
+8.47%
34.8M
+5.19%
33.1M
+13.81%
Balance Sheet
Cash and Cash Equivalents
74,631
+236.13%
22,203
-90.03%
222,665
+139.18%
93,095
-62.02%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
74,631
+236.13%
22,203
-90.03%
222,665
+139.18%
93,095
-62.02%
Total Current Assets
1,119
-90.84%
12,218
-46.89%
23,005
-92.67%
313,767
+958.20%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
286,500
+46.79%
195,171
-52.38%
409,845
+30.62%
313,767
-30.63%
Income Taxes Payable
199,444
+50.39%
132,615
+3.64%
127,963
+2.60%
124,718
+1.85%
Total Short-Term Debt
2.4M
-87.43%
18.7M
+926.22%
1.8M
-60.59%
4.6M
-3.56%
Total Current Liabilities
4.2M
-9.71%
4.6M
+50.11%
3.1M
-69.58%
10.1M
+20.72%
Total Long-Term Debt
4.3M
+134.50%
1.8M
-78.05%
8.4M
+43.33%
5.9M
+1,482.80%
Total Long-Term Liabilities
2,560
-59.54%
6,328
-23.18%
8,237
N/A
N/A
N/A
Total Liabilities
18.8M
+19.09%
15.8M
+21.18%
13.0M
+28.64%
10.1M
+20.72%
Retained Earnings
-46.2M
+10.83%
-41.7M
+14.64%
-36.3M
+16.57%
-31.2M
+21.29%
Total Stockholders Equity
-18.5M
+18.74%
-15.6M
+23.57%
-12.6M
+28.57%
-9.8M
+23.64%
Total Shares Outstanding
45.0M
+13.07%
39.8M
+10.39%
36.1M
+5.01%
34.4M
+5.60%
Cash Flow
Cash from Operating Activities
-2.7M
+14.32%
-2.3M
-25.20%
-3.1M
-7.10%
-3.4M
+21.77%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.7M
+27.44%
2.1M
-34.29%
3.3M
+1.29%
3.2M
+7.85%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-2,444.75%
+38.98%
-1,759.03%
+23.15%
-1,428.32%
-0.02%
-1,428.64%
-11.16%
Return on Equity
34.48%
-8.48%
37.68%
-18.12%
46.02%
-25.27%
61.58%
-7.57%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.0003
-88.46%
0.003
-65.33%
0.008
-75.73%
0.03
+782.86%
Cash Ratio
0.02
+272.92%
0.005
-93.35%
0.07
+684.78%
0.009
-68.49%
Debt-to-Equity Ratio
-0.36
-72.68%
-1.32
+62.99%
-0.81
-24.23%
-1.07
+63.93%
Debt-to-Assets Ratio
23.30
-77.91%
105.47
+322.95%
24.94
-25.42%
33.44
+192.22%

Earnings & Revenue History

Debt-to-Assets

Cash Flow